Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ENEA
Rome, Italyeneatechbiomedical.it ↗
- Ownership
- Private
- Employees
- ~40
- Development stage
- Other
01
Overview
ENEA Tech and Biomedical Foundation acts as an economic and strategic catalyst in Italy for technology transfer, investing in and developing startups and platforms in cell/gene therapy, diagnostics, and precision medicine; several portfolio assets are in clinical or near-commercial phases
- Therapeutic areas
- CardiovascularNeurologyRare DiseasesOtherOncology
- Modalities
- Cell therapyGene therapyMedical deviceDiagnostic technologySmall moleculeDigital healthOther
- Industry
- Investors
02
Partnerships
Approxima (MedTech investment)Tethis (Oncology diagnostics)Ri.MED Foundation (strategic biomedical R&D partnership)Indaco Venture Partners (co-investor in portfolio companies)Panakès Partners (co-investor)Various Italian universities and spin-offs
Beyond the preview
Go deeper on ENEA.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ENEA.